Exploring a Cardiovascular approach to patients with Type 2 Diabetes with a focus on current guidance
This webinar has been commissioned by Boehringer Ingelheim Limited and Lilly Diabetes Alliance and organised in partnership with Guidelines in Practice. See below for full disclaimer.
Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.
This webinar has been commissioned by Teva UK Limited and organised in partnership with Guidelines in Practice. See bottom of page for full disclaimer.
This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice.
Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)
Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.